Patients with SLE vs individuals without autoimmune disease demonstrated higher rates of peripartum complications.

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Background SLE is a systemic autoimmune disease with a large number of common risk gene variants, but several rare gene ...

Columnist Candace Semien applies the concept of radical responsibility to managing lupus and other chronic health conditions.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Among the research grants, Taimalieutu Kiwi Tamasese from The Family Centre has been awarded $80,000 in funding to lead a study on gout within Pasifika communities living in the Wellington and ...

Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...

Autoimmune disorders in children can cause symptoms often mistaken for common childhood illnesses. More precise diagnoses and ...

On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders.